Clinical Trial Update: MethylphenIdate for Fatigue in Haematological Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for methylphenidate as a treatment for fatigue in hematological cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematological Cancer

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Henrik Frederiksen | Conditions: Hematological Cancer | Phase 3 | Status: UNKNOWN